Article Text

Download PDFPDF
Design of a relative value unit-based tool for the measurement and reimbursement of pharmacy services for clinical trials
  1. Neus Pagès-Puigdemont1,2,
  2. Glòria Molas2,3,
  3. Maria Queralt Gorgas3,
  4. Núria Berga1,
  5. Carles Codina2,
  6. Miquel Cruel3,
  7. Begoña Gómez-Perez2,
  8. Mercè Espona4,
  9. Ainhoa Rodríguez-Arias1,
  10. Esther Salas4,
  11. Maria Antònia Mangues1
  1. 1 Pharmacy Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
  2. 2 Pharmacy Department, Hospital Clínic i Provincial de Barcelona, Barcelona, Spain
  3. 3 Pharmacy Department, Hospital Parc Taulí, Sabadell, Spain
  4. 4 Pharmacy Department, Hospital del Mar, Barcelona, Catalunya, Spain
  1. Correspondence to Dr Neus Pagès-Puigdemont, Pharmacy Department, Hospital de la Santa Creu i Sant Pau, Barcelona 08025, Spain; npages{at}


Objective To develop a relative value unit (RVU)-based tool for the measurement and reimbursement of pharmacy services for clinical trials.

Methods A portfolio of activities was agreed by consensus in four tertiary hospitals. Related activities were pooled into several categories or intermediate products. We recorded the duration of each activity by multiple determinations. We then calculated the average time of all determinations. The reference activity was assigned a value of 1. All other activities were compared to the reference activity to obtain the RVU. To establish which items should be invoiced to third parties for the activities performed, we defined the final products (different types of clinical trials according to their complexity).

Results Ten intermediate products and five final products were differentiated. Six intermediate products could be repeated over the course of a clinical trial and seven were performed whether or not the clinical trial had included patients. Each final product consisted of different categories. The total number of RVUs produced for a clinical trial was the sum of each constant category value plus the repetitive category values multiplied by the number of repetitions.

Conclusion The application of RVU methodology in investigational drug services allows a more precise quantification of services performed. After a prospective validation to confirm the applicability of this tool, it may contribute to more appropriate invoicing to third parties for these services.

  • cost analysis
  • clinical trials
  • investigational drug services
  • pharmacy services
  • rvu
  • relative value units

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.